<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR870.html">Part 870
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 870.3460  Endovascular Suturing System.
                            </h3>
                            <p class="depth1"><em>(a)</em> Identification. An endovascular suturing system is a medical device intended to provide fixation and sealing between an endovascular graft and the native artery. The system is comprised of the implant device and an endovascular delivery device used to implant the endovascular suture.</p><p class="depth1"><em>(b)</em> Classification. Class II (special controls). The special controls for this device are:</p><p class="depth2"><em>(1)</em> The device should be demonstrated to be biocompatible;</p><p class="depth2"><em>(2)</em> Sterility and shelf life testing should demonstrate the sterility of patient-contacting components and the shelf-life of these components;</p><p class="depth2"><em>(3)</em> Non-clinical and clinical performance testing should demonstrate substantial equivalence in safety and effectiveness, including durability, compatibility, migration resistance, corrosion resistance, and delivery and deployment;</p><p class="depth2"><em>(4)</em> Non-clinical testing should evaluate the compatibility of the device in an magnetic resonance (MR) environment;</p><p class="depth2"><em>(5)</em> Appropriate analysis and non-clinical testing should validate electromagnetic compatibility (EMC) and electrical safety;</p><p class="depth2"><em>(6)</em> The sale, distribution, and use of the device are restricted to prescription use in accordance with 21 CFR 801.109 of this chapter; and</p><p class="depth2"><em>(7)</em> Labeling must bear all information required for the safe and effective use of the device as outlined in Sec. 801.109(c) of this chapter, including a detailed summary of the non-clinical and clinical evaluations pertinent to use of the device.
[77 FR 8119, Feb. 14, 2012]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
